Red Mountain ready to commence drilling at Red Valley lithium project

|

Published 27-MAR-2017 15:56 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Finfeed presents this information for the use of readers in their decision to engage with this product. Please be aware that this is a very high risk product. We stress that this article should only be used as one part of this decision making process. You need to fully inform yourself of all factors and information relating to this product before engaging with it.

Red Mountain Mining (ASX:RMX) advised the market on Monday morning that it was mobilising a drilling rig with a view to commencement of exploration at its Red Valley lithium brines project in the next 7 to 10 days.

The Red Valley project is located in Western Utah, USA. RMX is conducting a three x 1000 foot well program to test for commercial levels of lithium enriched brine.

This news comes only a week after the group advised that it was entering into a binding exclusivity and earn-in agreement with CoCu Metals which controls 100% of the Mokabe-Kasiri cobalt-copper project in the Katanga province of the Democratic Republic of Congo, Africa.

The project comprises 350 square kilometres of the prolific Central African Copperbelt, and lies only 50 kilometres to the north of one of the world’s largest copper-cobalt mines, Tenke Fungurume, which is currently owned by a consortium including Toronto-based Lundin Mining and Phoenix-based Freeport McMoRan.

The Red Valley project already provided RMX with strong exposure to the new energy metal thematic, but this has been strengthened further by its interest in the Mokabe cobalt-copper project.

As drilling recommences at Red Valley there is the potential for multiple share price catalysts to emerge given laboratory results from grab samples at Mokabe have registered average cobalt grades of between 1.6% and 2.9%, as well as copper grading between 1.3% and 9.2%.

Of course it should be noted that this is an early stage play with no guarantee of share price catalysts, so investors should take a cautious approach to their investment decision and take all publicly available information into account.

tags

COPPER


General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X